BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 31

• Press Releases

  GeneDx Enhances the Power of its Interpretation Platform with Artificial Intelligence (AI) Powered Gene Ranker to Enable Faster and More Efficient Clinical Analysis

  March 13, 2025

   · 

  2 min read
• Press Releases

  Crown Bioscience Appoints John Gu as Chief Executive Officer

  March 13, 2025

   · 

  3 min read
• Press Releases

  GeneDx to Showcase Key Research and Innovation at the 2025 American College of Medical Genetics (ACMG) Annual Meeting

  March 13, 2025

   · 

  3 min read
• Press Releases

  YourChoice Therapeutics Announces Nature Publication

  March 13, 2025

   · 

  4 min read
• 

  Autoimmune disease

  Amgen’s Uplizna Deepens Response Against Myasthenia Gravis at 1 Year

  With what analysts are calling “strong” data, Amgen plans to file a regulatory submission for Uplizna, currently approved for a rare ocular autoimmune disorder, in myasthenia gravis, in the first half of 2025.

  March 13, 2025

   · 

  1 min read

   · 

  Tristan Manalac
• 

  Business

  Houston’s Life Sciences Scene Continues Boosting Its Reputation

  While Houston isn’t yet on the same level as major life sciences hubs, it has plenty to offer and room to grow, according to CNS Pharmaceuticals, RadioMedix and Greater Houston Partnership executives.

  March 13, 2025

   · 

  6 min read

   · 

  Angela Gabriel
• Press Releases

  Dogwood Therapeutics, Inc. Announces Pricing of $4.8 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

  March 13, 2025

   · 

  5 min read
• Press Releases

  NEXGEL to Participate in the iAccess Alpha Virtual Best Ideas Spring Investment Conference on March 25-26th, 2025

  March 13, 2025

   · 

  1 min read
• Press Releases

  Stealth BioTherapeutics Announces Achievement of 50% Enrollment Target in Phase 3 ReNEW Study of Elamipretide in Patients with Dry Age-Related Macular Degeneration

  March 13, 2025

   · 

  4 min read
• Press Releases

  RISE Robotics to be Awarded GUINNESS WORLD RECORDS™ title for Strongest Robotic Arm Prototype

  March 13, 2025

   · 

  1 min read